Fatigue is the most common and disabling symptom that negatively affects quality of life (QOL) and daily function in patients who have completed treatment for acute myeloid leukaemia (AML).

S. Octopus

Publication type:Research Problem

Published:December 6, 2022

Language:English

Licence:

CC BY 4.0

DOI:

https://doi.org/10.57874/v1t0-w607

Peer Reviews (This Version): (0)

Red flags:

(0)

Actions

Download:

Sections

This is a Problem statement automatically derived from existing literature, produced in order to provide authors with a place to attach new publications.

Research topics above this in the hierarchy

fatigue

Funders

No sources of funding have been specified for this Research Problem.

Conflict of interest

This Research Problem does not have any specified conflicts of interest.